---
title: COVID-19
---

# Hidroxicloroquina e Azitromicina

1. Gautret P, Lagier JC, Parola P, et al. [**Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial**](/listas/covid-19/Hydroxychloroquine_final_frances.pdf) [published online ahead of print, 2020 Mar 20]. Int J Antimicrob Agents. 2020;105949. doi:10.1016/j.ijantimicag.2020.105949.

    Esse foi o estudo francês responsável por causar todo o agitamento na ciência em busca de um remédio milagroso para curar a COVID-19.

    [Hidroxicloroquina: o dia em que a ciência parou](/listas/covid-19/hidroxicloroquina-o-dia-que-a-ciencia-parou.html): postagem no blog Medicina Baseada em Evidências criticando a interpretação apressada do estudo acima.


2. Sahraei Z, Shabani M, Shokouhi S, Saffaei A. **Aminoquinolines Against Coronavirus Disease 2019 (COVID-19): Chloroquine or Hydroxychloroquine** [published online ahead of print, 2020 Mar 16]. Int J Antimicrob Agents. 2020;105945. doi:10.1016/j.ijantimicag.2020.105945.
3. Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11. Published 2020 Mar 13. doi:10.1186/s40779-020-00240-0.
4. Cheng, V. C., Lau, S. K., Woo, P. C., & Yuen, K. Y. (2007). Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clinical microbiology reviews, 20(4), 660-694. https://doi.org10.1128/CMR.00023-07.
5. Menachery, V. D., Yount Jr, B. L., Debbink, K., Agnihothram, S., Gralinski, L. E., Plante, J. A., … & Randell, S. H. (2015). A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nature medicine, 21(12), 1508. https://doi.org/10.1038/nm.3985.
6. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;(February):1–6.
7. Muniz-Rodriguez K, Chowell G, Cheung C-H, Jia D, Lai P-Y, Lee Y, et al. Epidemic doubling time of the COVID-19 epidemic by Chinese province. medRxiv Prepr. 2020;
8.  Wang C, Liu L, Hao X, Guo H, Wang Q, Huang J, et al. Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China. medRxiv. 2020;
9.  Fan, Y.; Zhao, K.; Shi, Z.-L.; Zhou, P. Bat Coronaviruses in China. Viruses 2019, 11, 210.
10. Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe covid-19. N Engl J Med. April 2020:NEJMoa2007016. doi:10.1056/NEJMoa2007016.

# Distanciamento social

1. Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. [**Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period**](/listas/covid-19/Kissler2020.pdf) [published online ahead of print, 2020 Apr 14]. Science. 2020;eabb5793. doi:[10.1126/science.abb5793](https://doi.org/10.1126/science.abb5793).

    [O estudo que projetou distanciamento social até 2022 por causa da COVID-19](https://mosquildo.com.br/2020/medicina/o-estudo-que-projetou-distanciamento-social-ate-2022-por-causa-da-covid19): minha postagem comentando esse estudo.

# BCG

1. Miller A, Reandelar MJ, Fasciglione K, Roumenova V, Li Y, Otazu GH. [**Correlation between Universal BCG Vaccination Policy and Reduced Morbidity and Mortality for COVID-19: An Epidemiological Study**](/listas/covid-19/Miller2020-BCG-preprint.pdf). Epidemiology; 2020. Preprint medRxiv 2020.03.24.20042937; doi:[10.1101/2020.03.24.20042937](https://doi.org/10.1101/2020.03.24.20042937). 

    [Universal BCG vaccination and protection against COVID-19: critique of an ecological study](/listas/covid-19/nature-critica.html): postagem no blog da Nature criticando esse estudo.

# Gestantes

1. Alzamora MC, Paredes T, Caceres D, Webb CM, Valdez LM, La Rosa M. [**Severe COVID-19 during Pregnancy and Possible Vertical Transmission**](/listas/covid-19/Alzamora2020-pregnant-covid19.pdf) [published online ahead of print, 2020 Apr 18]. Am J Perinatol. 2020;10.1055/s-0040-1710050. doi:[10.1055/s-0040-1710050](https://doi.org/10.1055/s-0040-1710050).

    Relato de caso sobre uma evolução grave da COVID-19 em gestante que necessitou ser intubada e realizar cesárea de emergência. O neonato, mesmo sendo isolado do contato, apresentou *swab* nasal e RT-PCR positivos para o SARS-CoV-2. Possibilidade de transmissão vertical intra-útero? 